Plain-English translation of NCT05385406 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a genetic test that identifies specific types of HPV (a virus linked to cervical cancer) is better than a visual inspection method at finding women who truly need treatment. Right now, many women test positive for HPV but don't actually have precancerous changes—meaning they get treated unnecessarily. This study wants to see if the genetic approach is more accurate and wastes fewer resources on women who don't need treatment.
The current WHO-recommended visual inspection method depends heavily on the doctor's experience and can be unreliable in different settings. The genetic test approach may be more consistent and objective, potentially helping doctors treat only the women who truly need it while avoiding unnecessary procedures.
You would first receive an HPV screening test. If the test is positive, you would be randomly assigned to one of two groups: either receive a genetic test to identify your specific HPV type (and possibly immediate treatment if you have a high-risk type), or receive a visual inspection with acetic acid to determine if you need treatment. If you need treatment, the study offers a procedure called thermal ablation. You would have follow-up visits at 12 months to check your results.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Cameroon